Rich Rainey

Rich Rainey is currently the Chief Operations Officer at FPRT Bio. They have served as a Partner at Rainey & Rainey, CPAs since 1994, providing auditing and accounting services for private and public companies. Rich also holds the position of General Partner at 203 Investment Partners LLP, an investment firm focusing on real estate and biotechnology. Previously, they were the Chief Executive Officer of Avax Technologies, Inc., where they oversaw the development of cancer treatment technology. Rich began their career as an Auditor at Ernst & Young from 1988 to 1993 and earned a Bachelor of Science in Accounting from Pennsylvania State University.